| CYP2D6 allelic variants* 34,* 17-2,* 17-3, and* 53 and a Thr309Ala mutant display altered kinetics and NADPH coupling in metabolism of bufuralol and dextromethorphan and … SM Glass, CM Martell, AK Oswalt, V Osorio-Vasquez, C Cho, MJ Hicks, ... Drug Metabolism and Disposition 46 (8), 1106-1117, 2018 | 8 | 2018 |
| Dissecting the stability determinants of a challenging de novo protein fold using massively parallel design and experimentation TE Kim, K Tsuboyama, S Houliston, CM Martell, CM Phoumyvong, ... Proceedings of the National Academy of Sciences 119 (41), e2122676119, 2022 | 4 | 2022 |
| P134-Evaluation of CRISPR-CAS9 and CRISPR-CAS13 in modulating drug metabolizing enzymes L Chen, J Qiu, M Mohutsky, R Moulton, A Pak, A Borel, J Alberts, C Ochoa, ... Drug Metabolism and Pharmacokinetics 35 (1), S63-S64, 2020 | | 2020 |
| Evaluation of Small Interfering RNA Mediated Knockdown of Drug Metabolizing Enzymes as a Tool for Reaction Phenotyping CM Martell Kalamazoo College Chemistry Senior Individualized Projects Collection, 2019 | | 2019 |
| Allelic variants of CYP2D6 have altered drug metabolite profile, kinetics, and susceptibility to mechanism-based inactivation LL Furge, SM Glass, C Cho, CM Martell, JM Mills, AK Oswalt, S Leddy Drug Metabolism and Pharmacokinetics 33 (1), S31, 2018 | | 2018 |
